Adams Regulatory News (ADA)

27 Apr 2007 13:00

DawMed Systems PLC27 April 2007 27 APRIL 2007 DAWMED SYSTEMS PLC ("Dawmed" or "the Company") AGM STATEMENT At today's Annual General Meeting of DawMed, the medical devices company whichdesigns, manufactures, sells, distributes and services healthcaredecontamination equipment used by Secondary Care NHS Trust hospitals, privatehospitals and Primary Care practitioners and clinics, the Executive Chairman,Kevin Gilmore, commented: KEY POINTS: • Enhanced Product Portfolio gaining ground; • Good progress in areas referred to in 2006 Final Results Statement; • Export Department established; • Export Manager appointed; • New Wassenburg "pass through" WD machines now being delivered; • Wassenburg "Dry 300" cabinets selling well; • Litigation trial date allocated by Court; • Expansion of Support Services Department Engineers "Since it is only a month ago that your Company's Annual Report and Accountswere distributed to all shareholders, there is not a great deal that I can addto my Statement in that document. That said, as regards the litigation against the trade debtor whom your Companyclaims breached its contract with the Company, a date for trial has beenallocated by the Court towards the end of June 2007 and the Board remainsconfident of a satisfactory outcome of those proceedings. So far as the UK is concerned, there can be no doubt that, in common with almostall NHS supply chain companies, particularly SMEs, your Company has continued toexperience unprecedented levels of NHS cut backs on purchases of both capitalequipment and revenue supplies. However, the new NHS financial year began on 1April 2007 and it is to be expected that a more normal level of NHS businesswill soon be resumed. The Directors are pleased that the current wide range of products and serviceshas generated growing interest in the UK, but more particularly in the potentialfor export. In this regard an Export Department was established and an exportmanager appointed on 1 April 2007. Your Board anticipates that, in accordancewith your Company's declared strategy, this area of activity will not onlybenefit the Group directly through increased sales, but also indirectly bylessening the degree of dependence upon the NHS. Good progress is being made in all the other areas referred to in my 2006 FinalResults Statement and I hope to be able to inform the market of such progress inmore detail in the not too far distant future." All resolutions proposed at the Annual General Meeting were duly passed. --ENDS-- Enquiries: DawMed Systems plc Tel: 01789 740 010Kevin Gilmore, Executive Chairman Beaumont Cornish Limited Tel: 020 7628 3396Roland Cornish Bishopsgate Communications Limited Tel: 020 7562 3350Dominic BarrettoJenni Herbert For further information please visit DawMed's website at www.dawmed.com This information is provided by RNS The company news service from the London Stock Exchange